NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period of 167 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod · last filed 2020-03-10
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2016-01-02 was -1.03M shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2015-10-03 was 339.31K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2015-07-04 was 751.02K shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for the quarter ending 2015-04-04 was 451.74K shares, a 299.23% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2019 was 167.00 shares, a 49.85% decline from fiscal 2018.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2018 was 333.00 shares.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2016 was 514.02K shares, a 1262.84% increase from fiscal 2015.
- NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2015 was 37.72K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | 167.00 shares 10-K · filed 2020-03-10 | ||||
| 2018-12-31 | 333.00 shares 10-K · filed 2020-03-10 | ||||
| 2016-01-02 | -1.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -688.74K shares derived: sum of 2 quarters · filed 2018-03-15 | 62.29K shares derived: sum of 3 quarters · filed 2018-03-15 | 514.02K shares 10-K · filed 2018-03-15 | 1.54M shares 10-K · filed 2016-03-17 |
| 2015-10-03 | 339.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 1.09M shares derived: sum of 2 quarters · filed 2015-11-12 | 1.54M shares 10-Q · filed 2015-11-12 | 1.47M shares derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-07-04 | 751.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 1.20M shares 10-Q · filed 2015-08-13 | 1.13M shares derived: sum of 3 quarters · filed 2017-03-16 | 1.13M shares derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-04-04 | 451.74K shares 10-Q · filed 2015-05-14 | 376.30K shares derived: sum of 2 quarters · filed 2017-03-16 | 376.30K shares derived: sum of 3 quarters · filed 2017-03-16 | 376.30K shares derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-01-03 | -75.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -75.43K shares derived: sum of 2 quarters · filed 2017-03-16 | -75.43K shares derived: sum of 3 quarters · filed 2017-03-16 | 37.72K shares 10-K · filed 2017-03-16 | 113.15K shares 10-K · filed 2015-03-19 |
| 2014-09-27 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-06 | 113.15K shares 10-Q · filed 2014-11-06 | ||
| 2014-06-28 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 113.15K shares 10-Q · filed 2014-08-12 | |||
| 2014-03-29 | 113.15K shares 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |